Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody
Clinical trial NCT02695797 · UNKNOWN
Trial details
- NCT number
- NCT02695797
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.